[1]
R. L. Pacheco, H. Mamede, D. Wiltgen, and A. Stein, “Methylprednisolone versus dexamethasone for Covid-19 patients: an analysis of a published clinical trial”, Evidence, vol. 3, p. e3814, Jan. 2022, doi: 10.17267/2675-021Xevidence.2021.e3814.